AKT1 and breast carcinoma: We observe in several breast cancer cells displaying high Akt activity and low SGK1 (including BT-474, CAMA-1 and T47D) that NDRG1 is still phosphorylated and that NDRG1 phosphorylation is suppressed by Akt inhibitors.